Join Dr. Christine McKinney for an inside look at Mometamax Single®, a unique in‑clinic therapy for canine otitis externa. In this short video, she highlights its key features, clinical advantages, and supporting scientific evidence, including how this treatment can make a meaningful difference in your otitis externa cases. She provides an overview of posaconazole, a new topical antifungal now available in Canada, and discusses how Mometamax Single® offers a valuable option for managing those...

Join Dr. Mel Pinel on September 15, 2026, at 7 p.m. ( EDT) for this 30-minute live webcast on Credelio Quattro® to explore vector-bourne disease, key gaps in parasite protection, and the new monthly chewable that provides broad-spectrum against fleas, ticks, heartworms, lungworms, roundworms, hookworms, and zoonotic tapeworms. With More in One™, Credelio Quattro addresses critical gaps in canine wellness by delivering broad-spectrum parasite protection in a single monthly chew. Be among the...

Do you think you know Onsior® (robenacoxib) well? Put your knowledge to the test with this short 10-question quiz covering Onsior®’s indications, safety profile, COX-2 selectivity, pharmacokinetic properties, and clinical use in dogs and cats. Whether you're looking to validate your knowledge or discover a few interesting facts, this quiz offers a simple and interactive way to learn more about Onsior®. You'll also have access to informative tools and resources throughout the quiz. Complete...

Join Dr. Laura Harrison, on October 28, 2026, at 7 p.m. (EDT), for a 30-minute live webcast to explore Numelvi®, a new first-line treatment option for canine allergic dermatitis. Learn more about the First and Only Second-Generation JAK inhibitor that provides an effective first-line treatment for dogs, 6 months of age and older, and is indicated for the control of pruritus associated with allergic dermatitis. This webcast is a sponsored presentation hosted by CommuniVET™. All content,...

Dr. Tamara Brown presents, in this webcast, practical strategies for the management of otitis externa in dogs, as well as Simplera®. Ear infections were the most common condition reported in dogs, as per the 2024 Canadian Animal Health Institute (CAHI) Pet Owner Survey1. This Vetoquinol Product Spotlight offers practical tips and strategies to help manage otitis externa in your practice. It also highlights the key features and benefits of Simplera®, Vetoquinol’s newest solution for otitis...

BRAVECTO® QUANTUM, the first and only injection providing up to 12-months of flea and tick protection with built-in compliance. This webcast is a sponsored presentation hosted by CommuniVET™. All content, opinions, and product information shared during the event are provided by the sponsor. CommuniVET™ does not endorse or promote any specific products or companies. This webcast is not accredited for continuing education.

Watch this video as Dr. Anthony Yu explains why he considers Claro® the first-line treatment for ear infections. He discusses its key ingredients and emphasizes its ease of use, highlighting the advantages Claro® provides for both veterinary teams and pet owners.

Taking this short 10-question quiz is as simple as administering oral prescription once-daily medication to improve glycemic control in cats newly diagnosed with diabetes mellitus. Ok…not quite as simple, but quick and fun regardless! SenvelgoTM is an easy-to-give, once-daily oral liquid solution that provides a time- and cost-efficient way to extend the lives of feline diabetic patients. SenvelgoTM is a trademark of Boehringer Ingelheim Vetmedica Inc., used under license.© 2024 Boehringer...

Watch this video as Dr. Tony Yu presents the many benefits of Claro, a first-line treatment for ear infections in pets. By being administered directly in the clinic, Claro relieves pet owners of the burden of at-home treatments. Dr. Yu also provides a detailed explanation of the proper administration of Claro to ensure optimal effectiveness and discusses why it's an ideal solution for managing ear infections in your patients.